Document ID: chunk:federal_register_of_legislation:F2024L01648:clause:1_1
Version: federal_register_of_legislation:F2024L01648
Segment Type: clause
Provision Reference: sch 1 cl 1
Character Range: 4984–9315

1                                                                                                    PROTAPHANE INNOLET human insulin (rys) 100 IU/mL injection multidose cartridge, registration number 169633  PROTAPHANE PENFILL human insulin (rys) 100 IU/mL injection multidose cartridge, registration number 169635  one 3 mL (300 IU) cartridge of the substitutable medicine is equivalent to one 3 mL (300 IU) pre‑filled cartridge of the scarce medicine  the pharmacist has:
                                                                                                                                                                                                                                                                                                                                                                                                                                                                         (a) ensured the patient, or person acting on behalf of the patient, has, or is given, a suitable insulin delivery system to administer the substitutable medicine; and
                                                                                                                                                                                                                                                                                                                                                                                                                                                                         (b) advised the patient, or person acting on behalf of the patient:
                                                                                                                                                                                                                                                                                                                                                                                                                                                                           (i) of suitable instructions for safely and effectively administering the substitutable medicine, including using the insulin delivery system; or
                                                                                                                                                                                                                                                                                                                                                                                                                                                                           (ii) where the pharmacist is unable to provide suitable instructions—to obtain suitable instructions for administering the substitutable medicine, including using the insulin delivery system, from the prescriber, a suitably qualified health practitioner or a credentialed diabetes educator; and
                                                                                                                                                                                                                                                                                                                                                                                                                                                                         (c) advised the patient, or person acting on behalf of the patient, of the number of dose units of substitutable medicine that must be administered to the patient in substitution for the prescribed dose of scarce medicine, based on the dose unit equivalence specified in column 4; and
                                                                                                                                                                                                                                                                                                                                                                                                                                                                         (d) advised the patient, or person acting on behalf of the patient, of the differences between the scarce medicine and the substitutable medicine